Идёт набор NCT07016035

Translation and Validation of the French mPCOSQ (mPCOSQ-F).

— Наблюдательное Polycystic Ovary Syndrome Health-related Quality of Life

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: В протоколе указаны: mPCOSQ-F and SF-36.
Кому может быть актуально: Состояния в реестре: Polycystic Ovary Syndrome Health-related Quality of Life. Базовые параметры: 18 лет — 45 лет · Женщины.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: Франция
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Translation and Validation of the French Version of the Health-related Quality of Life Questionnaire for the Polycystic Ovary Syndrome: the mPCOSQ-F.

Обзор

This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.

Подробное описание

The aim of this study is to assess the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome.

Women aged 18 to 45 years with a diagnosis of polycystic ovary syndrome will be included.

The first stage of the study consisted in translating the questionnaire from English to French.

Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.

The pre-test phase purpose is to appraise the face validity and feasibility of the questionnaire through phone interviews with the thirty first respondents.

In the final phase, we aimed to evaluate the validity and reliability of the mPCOSQ, and to compare it to the SF-36.

Вмешательства

Другое mPCOSQ-F and SF-36
Questionnaires

Первичные конечные точки

Content validity of mPCOSQ as determined by the experts group [Срок оценки: At 2 years]
Feasibility of mPCOSQ [Срок оценки: At 2 years]
Acceptability of mPCOSQ [Срок оценки: At 2 years]
Structure validity of mPCOSQ [Срок оценки: At 2 years]
Reproductibility of mPCOSQ [Срок оценки: At 2 years]
Reliabilty of mPCOSQ [Срок оценки: At 2 years]
Total mPCSOQ score [Срок оценки: At 15 days]
SF-36 scores [Срок оценки: At 1 day]
Scores in the " weight " domain based on BMI [Срок оценки: At 1 day]
Scores in the " fertility " domain based on the need for reproductive medicine or parenthood [Срок оценки: At 1 day]

Критерии участия

Критерии включения

Women aged 18 to 45
Fluent in french
Having a diagnosis of PCOS according to the international recommendations published in 2023
Willing to participate in the study
Affiliated to the french social security system